The Aspirin-maker is suffering from complications of its acquisition of Monsanto
1899 acetylsalicylic acid, better known as Aspirin, was registered at the imperial patent office in Berlin. The first-ever synthetic drug went on to become one of the world’s most successful medicines. On Aspirin’s 125th birthday its maker, Bayer, is in no mood for schnapps.
Bayer certainly needs more than a painkiller. Last year it made a net loss of almost €3bn . Sales fell by 6%. It has torched 70% in shareholder value since June 2018, when it completed the acquisition of Monsanto, an American agrochemical giant . If the company is to recover, Mr Anderson must first and foremost undo that deal’s toxic legacy.The $63bn Bayer splurged on Monsanto turned out to be just a downpayment.
All this may have made it harder to replenish its dwindling drug pipeline. The patents for two bestsellers, Eylea, an eye drug, and Xarelto, a blood-thinner, expire in 2025 and 2026 respectively. In November Bayer stopped testing an anti-clotting drug it had hoped could generate more than €5bn in annual sales, after trials showed disappointing efficacy. Another bet, Elinzanetant, a menopause medicine in late-stage testing, looks more promising.
To start the healing process, Mr Anderson has trimmed dividends by 95% and announced large job cuts. He wants to do away with chunks of a 1,326-page book of internal rules for managers and halve the number of management layers from 12 to six. “We hire brilliant people. They don’t need baby-sitters,” he says. The organisational changes may cut annual costs by €2bn, or nearly as much as Bayer spends on administrative expenses, by 2026.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Daily aspirin linked to higher mortality in older adults, study findsA study from the ASPREE clinical trial found that daily aspirin intake in adults over 70 did not increase disability-free survival and was associated with higher all-cause mortality, primarily due to cancer-related deaths.
Read more »
What Xabi Alonso did after Bayer Leverkusen beat Bayern Munich speaks volumes amid Liverpool rumoursXabi Alonso produced a great gesture after Bayer Leverkusen's big win over Bayern Munich.
Read more »
Granit Xhaka had Xabi Alonso worried with celebration after scoring for Bayer LeverkusenEx Arsenal star Granit Xhaka scored a stunning opener for Bayer Leverkusen but his celebration worried many.
Read more »
Arsenal cult hero Granit Xhaka trolls Xabi Alonso with celebration after stunner to open Bayer Leverkusen...Danny Murphy discusses whether Thomas Tuchel and Jurgen Klopp could swap jobs next season or if Xabi Alonso could be their potential successor
Read more »
'P**sed off' Thomas Muller absolutely rages in explosive post-match interview after Bayern Munich defeatThomas Muller didn't hold back when assessing Bayern Munich's defeat at Bayer Leverkusen.
Read more »
Jeremie Frimpong reveals plan to stop young footballers from being 'destroyed' after harsh Man City lessonBayer Leverkusen star Jeremie Frimpong tells SPORTbible about his new project set up to help young footballers who face rejection.
Read more »